drugset / Trial / NCT00716092
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to investigate the effect of BI 1356 on 24-h glucose control and various pharmacodynamic parameters in type 2 diabetic patients with inadequate glycaemic control.
Timeline
- Start
- 2008-07
- Primary completion
- 2008-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Small molecule | 5 mg | Oral |
| Comparator | Sitagliptin | Small molecule | 100 mg | Oral |